FDA Drug Application (021925) for DUETACT by TAKEDA PHARMS USA

Back to FDA Applications sponsored by TAKEDA PHARMS USA

Application Number021925
Product Number001
FormTABLET;ORAL
Dosage2MG;30MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDUETACT
Active IngredientGLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE



Back to FDA Applications sponsored by TAKEDA PHARMS USA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.